Skip to main content
Retour
Watch Compare

Cannabis Bioscience International Holdings, Inc.

Qualité des données : 100%
CBIH
OTC Services Engineering & Management Services
0,00 €
▼ 0,00 € (-20,00%)
Cap. Boursière: 5,81 M
Prix
0,00 €
Cap. Boursière
5,81 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -408 419,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)21,77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-333,39%
Op. Margin-245,25%

Sécurité

Debt / Equity
N/A
Current Ratio0,02
Interest Coverage-2,92

Valorisation

PE (TTM)
-8,65
En dessous de la moyenne du secteur (-1,21)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (506 pairs)
Métrique Action Médiane du Secteur
P/E -8,7 -1,2
P/B — 1,4
ROE % — -15,8
Net Margin % -333,4 -18,3
Rev Growth 5Y % — 4,0
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2026 — 369 000,01 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 21,77% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 201 601,0 Net Income (TTM) -672 127,0
ROE N/A ROA -3272,84%
Gross Margin 75,01% Operating Margin -245,25%
Net Margin -333,39% Free Cash Flow (TTM) -408 419,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,02
Interest Coverage -2,92 Asset Turnover 9,82
Working Capital -1,11 M Tangible Book Value -1,36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8,65 Forward P/E N/A
P/B Ratio N/A P/S Ratio 28,84
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7,03%
Market Cap 5,81 M Enterprise Value 6,10 M
Per Share
EPS (Diluted TTM) 0,00 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 60,77%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 303 022,0 248 841,0
Net Income -548 820,0 -651 345,0
EPS (Diluted) 0,00 0,00
Gross Profit 262 916,0 203 242,0
Operating Income -421 365,0 -486 140,0
EBITDA — —
R&D Expenses — —
SG&A Expenses — —
D&A — —
Interest Expense 136 262,0 154 206,0
Income Tax — 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 31 880,0 57 162,0
Total Liabilities 1,20 M 1,14 M
Shareholders' Equity -1,16 M -1,08 M
Total Debt 286 187,0 256 415,0
Cash & Equivalents — —
Current Assets 29 085,0 21 492,0
Current Liabilities 945 963,0 881 908,0